Bioptimus partners with Cancer Research Horizons to advance AI-powered precision medicine

Bioptimus to use Cancer Research Horizons’ data to train and evaluate its AI foundation model Third partnership since Bioptimus launched ground-breaking STELA initiative in March Deal adds Bioptimus' first UK patient cohort to...

Imagene AI: Integration with Proscia’s Concentriq platform will facilitate pharma companies, diagnostic assay and platform providers, and CROs in operationalizing companion diagnostic programs August 18, 2026  Imagene AI, a leader in...

Nucleai, Gilead, and target-positive tumors Antibody-drug conjugates (ADCs) have emerged as one of the busiest and most crowded niches within oncology, given their potential to use an antibody to ferry a potent cytotoxic payload toward...

Lumea: Company Recognized for Large Revenue Growth, Earning a Place Among the Nation’s Most Successful Independent Businesses LEHI, UT, UNITED STATES, August 11, 2026 /EINPresswire/ — Lumea today announced it has been ranked No. 1,641 on...

aetherAI: Delivering Integrated Software-and-Hardware Consulting Solutions for the Global Digital Transformation of Pathology — Growth Momentum Poised to Accelerate aetherAI (7803), a global leader in digital pathology and AI healthcare...

The partnership brings elea’s pathology-specific AI directly into Techcyte Fusion, enabling pathologists to turn assessments into structured, coded reports. OREM, UT, UNITED STATES, August 13, 2026 /EINPresswire.com/ -- Techcyte today...